Proteomics of pediatric heart failure: From traditional biomarkers to new discovery strategies

Mingguo Xu, Genaro A. Ramirez-Correa, Anne M Murphy

Research output: Contribution to journalArticle

Abstract

Heart failure in children is a complex clinical syndrome with multiple aetiologies. The underlying disorders that lead to heart failure in children differ significantly from those in adults. Some clinical biomarkers for heart failure status and prognosis appear to be useful in both age groups. This review outlines the use and the present status of biomarkers for heart failure in paediatric cardiology. Furthermore, clinical scenarios in which development of new biomarkers might address management or prognosis are discussed. Finally, strategies for proteomic discovery of novel biomarkers and application to practice are described.

Original languageEnglish (US)
Pages (from-to)51-57
Number of pages7
JournalCardiology in the Young
Volume25
Issue numberS2
DOIs
StatePublished - Sep 17 2015

Fingerprint

Proteomics
Heart Failure
Biomarkers
Pediatrics
Cardiology
Age Groups

Keywords

  • Biomarker
  • heart failure
  • post-translational modification
  • proteomics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Proteomics of pediatric heart failure : From traditional biomarkers to new discovery strategies. / Xu, Mingguo; Ramirez-Correa, Genaro A.; Murphy, Anne M.

In: Cardiology in the Young, Vol. 25, No. S2, 17.09.2015, p. 51-57.

Research output: Contribution to journalArticle

@article{2cc31c9bfaeb4158a668030a36f10945,
title = "Proteomics of pediatric heart failure: From traditional biomarkers to new discovery strategies",
abstract = "Heart failure in children is a complex clinical syndrome with multiple aetiologies. The underlying disorders that lead to heart failure in children differ significantly from those in adults. Some clinical biomarkers for heart failure status and prognosis appear to be useful in both age groups. This review outlines the use and the present status of biomarkers for heart failure in paediatric cardiology. Furthermore, clinical scenarios in which development of new biomarkers might address management or prognosis are discussed. Finally, strategies for proteomic discovery of novel biomarkers and application to practice are described.",
keywords = "Biomarker, heart failure, post-translational modification, proteomics",
author = "Mingguo Xu and Ramirez-Correa, {Genaro A.} and Murphy, {Anne M}",
year = "2015",
month = "9",
day = "17",
doi = "10.1017/S1047951115000839",
language = "English (US)",
volume = "25",
pages = "51--57",
journal = "Cardiology in the Young",
issn = "1047-9511",
publisher = "Cambridge University Press",
number = "S2",

}

TY - JOUR

T1 - Proteomics of pediatric heart failure

T2 - From traditional biomarkers to new discovery strategies

AU - Xu, Mingguo

AU - Ramirez-Correa, Genaro A.

AU - Murphy, Anne M

PY - 2015/9/17

Y1 - 2015/9/17

N2 - Heart failure in children is a complex clinical syndrome with multiple aetiologies. The underlying disorders that lead to heart failure in children differ significantly from those in adults. Some clinical biomarkers for heart failure status and prognosis appear to be useful in both age groups. This review outlines the use and the present status of biomarkers for heart failure in paediatric cardiology. Furthermore, clinical scenarios in which development of new biomarkers might address management or prognosis are discussed. Finally, strategies for proteomic discovery of novel biomarkers and application to practice are described.

AB - Heart failure in children is a complex clinical syndrome with multiple aetiologies. The underlying disorders that lead to heart failure in children differ significantly from those in adults. Some clinical biomarkers for heart failure status and prognosis appear to be useful in both age groups. This review outlines the use and the present status of biomarkers for heart failure in paediatric cardiology. Furthermore, clinical scenarios in which development of new biomarkers might address management or prognosis are discussed. Finally, strategies for proteomic discovery of novel biomarkers and application to practice are described.

KW - Biomarker

KW - heart failure

KW - post-translational modification

KW - proteomics

UR - http://www.scopus.com/inward/record.url?scp=84941914358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941914358&partnerID=8YFLogxK

U2 - 10.1017/S1047951115000839

DO - 10.1017/S1047951115000839

M3 - Article

C2 - 26377710

AN - SCOPUS:84941914358

VL - 25

SP - 51

EP - 57

JO - Cardiology in the Young

JF - Cardiology in the Young

SN - 1047-9511

IS - S2

ER -